CCC

CYXONE AB

No trades
See on Supercharts
Market capitalization
‪8.76 M‬SEK
−0.2290SEK
‪−22.99 M‬SEK
‪55.90 M‬
Beta (1Y)
−0.83

About CYXONE AB

CEO
Carl Magnus Högerkorp
Headquarters
Malmö
Website
Employees (FY)
3
ISIN
SE0007815428
FIGI
BBG00CP2TWX3
Cyxone AB is a clinical stage biotechnology company, which engages in the development of immunomodulation drugs for the treatment of autoimmune diseases. Its product portfolio include T20K for multiple sclerosis in a preclinical program; and Rabeximod for rheumatoid arthritis and Covid-19. The company was founded by Bert Roland Kari Junno in July 13, 2015 and is headquartered in Malmo, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CYXO is 0.0910 SEK — it has increased by 2.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange CYXONE AB stocks are traded under the ticker CYXO.
CYXO stock is 12.87% volatile and has beta coefficient of −0.83. Check out the list of the most volatile stocks — is CYXONE AB there?
Yes, you can track CYXONE AB financials in yearly and quarterly reports right on TradingView.
CYXO stock has risen by 0.66% compared to the previous week, the month change is a 12.35% rise, over the last year CYXONE AB has showed a 86.60% decrease.
CYXO net income for the last quarter is ‪−6.99 M‬ SEK, while the quarter before that showed ‪−5.20 M‬ SEK of net income which accounts for −34.57% change. Track more CYXONE AB financial stats to get the full picture.
Today CYXONE AB has the market capitalization of ‪8.76 M‬, it has increased by 5.01% over the last week.
No, CYXO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CYXO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CYXONE AB stock right from TradingView charts — choose your broker and connect to your account.
CYXO reached its all-time high on Oct 6, 2017 with the price of 13.5804 SEK, and its all-time low was 0.0780 SEK and was reached on Apr 3, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 3.00 employees. See our rating of the largest employees — is CYXONE AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CYXONE AB technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CYXONE AB stock shows the sell signal. See more of CYXONE AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.